Relafen 750, also known as naproxen, signifies a fascinating case study for biochemical pharmacy. Its mechanism of action involves the suppression of cyclooxygenase proteins, specifically COX-1 and COX-2, consequently alleviating prostaglandin synthesis . Analyzing the subtle interplay within Relafen 750 and these enzymatic pathways provides valuab